To cite this paper use one of the standards below:
Tuberculosis (TB) is an infectious disease caused by the pathogen Mycobacterium tuberculosis, which is one of the major causes of death worldwide. Thus, this work aimed to evaluate the interaction of different classes of β-lactam antibiotics with the penicillin-binding protein (PBP) PonA1 from mycobacteria and then, contribute to the repositioning of antimicrobials for the tuberculosis treatment. PonA1 is involved in the peptidoglycan biosynthesis, a component of cell wall responsible for the pathogenic success of these organisms. It is well known that β-lactam can inhibit PBPs, however, characterization of their interaction with PonA1 has been vaguely reported. Thus, the first steps of this work consisted in optimizing the expression and purification conditions in the soluble fraction. Next, the enzyme was subjected to differential scan fluorimetry (DSF) analysis to identify which β-lactam disturbs the enzyme's thermal stability and the selected will be used in the inhibition assay utilizing the hydrolysis of nitrocefin.
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
This proceedings is identified by a DOI , for use in citations or bibliographic references. Attention: this is not a DOI for the paper and as such cannot be used in Lattes to identify a particular work.
Check the link "How to cite" in the paper's page, to see how to properly cite the paper